Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 28;191(4):E93-E99.
doi: 10.1503/cmaj.180694.

The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis

Matthew A Weir  1 , Justin Slater  2 , Racquel Jandoc  2 , Sharon Koivu  2 , Amit X Garg  2 , Michael Silverman  2
Affiliations

The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis

Matthew A Weir et al. CMAJ. .

Abstract

Background: Infective endocarditis is an increasingly common complication among people who inject drugs. We conducted this study to determine whether the removal of traditional controlled-release oxycodone from the Canadian market would be associated with an increase in the use of hydromorphone and an increased risk of infective endocarditis.

Methods: We conducted a retrospective, population-based time series analysis using the linked health administrative databases of Ontario, Canada. We measured the quarterly risk of admissions for infective endocarditis related to injection drug use and changes in opioid prescription rates from 2006 to 2015. We set the intervention point at the fourth quarter of 2011, when traditional controlled-release oxycodone was removed from the Canadian market.

Results: We observed an increase in the risk of admissions for infective endocarditis related to injection drug use during the study period. Before the intervention point, we observed a mean of 13.4 admissions per quarter, and after the intervention, we observed a mean of 35.1 admissions per quarter. However, no significant change in this risk occurred at the intervention point. Rather, the risk of infectious endocarditis appeared to have increased earlier and in parallel with the rise in hydromorphone prescriptions. Hydromorphone represented 16% of all opioid prescriptions at the start of the observation period and 53% by the end.

Interpretation: The risk of infective endocarditis related to injection drug use is increasing and is temporally associated with increasing prescriptions for hydromorphone. This relation warrants further exploration.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1:
Figure 1:
Quarterly percentage of patients with evidence of injection drug use admitted with infective endocarditis. The point at which traditional controlled-release oxycodone was removed from the market is marked as “intervention point.”
Figure 2:
Figure 2:
Quarterly prescriptions for traditional controlled-release oxycodone and hydromorphone as percentages of total opioid prescriptions.
Figure 3:
Figure 3:
Quarterly prescriptions for hydromorphone as a percentage of total opioid prescriptions and the risk of infective endocarditis related to injection drug use.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2016; 64: 1378–82. - PubMed
    1. Fischer B, Gooch J, Goldman B, et al. Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later. Can J Public Health 2014;105:e146–9. - PMC - PubMed
    1. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003; 89: 577–81. - PMC - PubMed
    1. Olubamwo O, Onyeka IN, Aregbesola A, et al. Association between route of illicit drug administration and hospitalizations for infective endocarditis. SAGE Open Med 2017;5:1–5. - PMC - PubMed
    1. Tung MKY, Light M, Giri R, et al. Evolving epidemiology of injecting drug use-associated infective endocarditis: a regional centre experience. Drug Alcohol Rev 2015;34:412–7. - PubMed

MeSH terms